Elicera Therapeutics AB (publ) (STO:ELIC)

Elicera Therapeutics AB Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	45.65	26.4	29.38	43.82	52.39	11.56
Cash & Short-Term Investments	45.65	26.4	29.38	43.82	52.39	11.56
Cash Growth	12.15%	-10.15%	-32.95%	-16.36%	353.04%	34087.00%
Other Receivables	0.73	0.88	0.34	0.33	0.2	0.45
Receivables	0.73	0.88	0.34	0.33	0.2	0.45
Prepaid Expenses	-	0.28	0.45	1.65	1.62	0.05
Other Current Assets	-	-	-	-0	-0.01	-
Total Current Assets	46.38	27.57	30.17	45.8	54.21	12.06
Long-Term Investments	-	0	0	0.48	0.48	0.48
Other Intangible Assets	-	-	0.01	0.02	0.04	0.05
Other Long-Term Assets	-	-	-	-0	0.01	-
Total Assets	46.38	27.57	30.18	46.31	54.74	12.59
Accounts Payable	3.83	2.04	0.88	0.73	2.05	1.95
Accrued Expenses	8.72	4.4	12.5	12.53	0.31	0.29
Current Income Taxes Payable	-	-	-	0.01	0	0
Other Current Liabilities	1.08	0.35	0.4	0.24	0.14	0.11
Total Current Liabilities	13.63	6.8	13.78	13.51	2.5	2.35
Total Liabilities	13.63	6.8	13.78	13.51	2.5	2.35
Common Stock	2.04	1.47	0.83	0.83	0.83	0.51
Additional Paid-In Capital	106.06	86.62	66.79	66.79	66.79	11.99
Retained Earnings	-75.34	-67.33	-51.22	-34.82	-15.38	-2.26
Comprehensive Income & Other	-	-	-	-0	-0	-
Shareholders' Equity	32.75	20.77	16.4	32.8	52.24	10.24
Total Liabilities & Equity	46.38	27.57	30.18	46.31	54.74	12.59
Net Cash (Debt)	45.65	26.4	29.38	43.82	52.39	11.56
Net Cash Growth	12.15%	-10.15%	-32.95%	-16.36%	353.04%	34087.00%
Net Cash Per Share	1.28	0.84	1.49	2.21	3.27	0.96
Filing Date Shares Outstanding	48.54	35.09	19.78	19.78	19.78	12.03
Total Common Shares Outstanding	48.54	35.09	19.78	19.78	19.78	12.03
Working Capital	32.75	20.77	16.39	32.29	51.71	9.71
Book Value Per Share	0.67	0.59	0.83	1.66	2.64	0.85
Tangible Book Value	32.75	20.77	16.39	32.78	52.2	10.19
Tangible Book Value Per Share	0.67	0.59	0.83	1.66	2.64	0.85

Source: S&P Global Market Intelligence. Standard template. Financial Sources.